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CARDIOTHORACIC IMAGINGLate left atrial thrombosis of an Amplatzer patent foramen ovale
occluderStefan Klotz, MD,a Maximillian Gebhard, MD,b and Hans H. Sievers, MDaFIGURE 1. Transesophageal echocardiography shows the PFO Amplat-
zer occluder (AGA Medical Corp, Plymouth, Minn) (double arrow) with
a mass in the left atrium (arrowhead).In February 2007, a 51-year-old man was admitted to the
neurology department with aphasia. Diagnostic examina-
tion revealed a patent foramen ovale (PFO) that was suc-
cessfully occluded with an Amplatzer occluder (AGA
Medical Corp, Plymouth, Minn) in March of 2007. The
postoperative course was uneventful. He received oral
therapy with aspirin and Coumadin for 6 months.
Two and a half years later in December 2010, the patient
returned to the hospital with aphasia. Cerebral computer
scan showed a left frontal 9- 3 7-mm lesion. Further diag-
nostic examination with transesophageal echocardiography
revealed a huge mass in the left atrium directly on top of the
Amplatzer occluder. A thrombus was suspected, so therapy
with heparin and concomitant Coumadin (Bristol-Myers
Squibb, New York, NY) was initiated. A complete hemato-
logic survey, including platelet function and coagulation
factors, showed no pathologic findings. In February 2011,
transesophageal echocardiography verified that the left
atrial mass had progressed (Figure 1). Magnetic resonance
tomography could not distinguish between thrombus and
myxoma, so cardiac surgery was scheduled.
During cardiac surgery, the Amplatzer PFO occluder and
the left atrial mass were excised completely (Figure 2). The
septal defect was closed with pericardium. The postopera-
tive coursewas uneventful. Histology revealed an organized
thrombus with proliferating connective tissue and capillar-
ies (Figure 3).
DISCUSSION
Interventional occlusion for PFO is a standard procedure.
Whether this is beneficial in contrast with medical therapy
alone in patients with cryptogenic stroke will be analyzed.1
Although right atrial thrombosis of an Amplatzer occluder
has been reported,2 thrombosis in the left atrium has not
been. In a large series of 620 patients with the Amplatzer
PFO occluder for secondary prevention of paradoxical
embolism, only 2 small thrombi were seen on the atrial
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1270 The Journal of Thoracic and Cardiovascular Suranticoagulation. No thrombus was seen after a median
follow-up of 2.6 years.3CONCLUSIONS
This report describes a late large thrombosis of the atrial
disk of an Amplatzer PFO occluder implanted 33 months
after the initial implantation.FIGURE 2. Explanted device with the mass sitting on the left atrial disk.
gery c November 2011
FIGURE 3. Histology of the organized thrombus.
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